Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultratrace Iobenguane I 131 in Relapsed/Refractory High-Risk Neuroblastoma
NCT00659984Phase 2Completed
- Sponsor
- Molecular Insights Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ultratrace iobenguane I 131 in neuroblastoma, sponsored by Molecular Insights Pharmaceuticals. Started Jun 2008; status: completed.
02
Drugs
Ultratrace iobenguane I 131
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00659984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659984.